Title: Moritz Bunemann: Innovator in cAMP Research
Introduction
Moritz Bunemann is a notable inventor based in Germany, recognized for his contributions to the field of biochemistry, particularly in the study of cyclic adenosine monophosphate (cAMP). His innovative work focuses on the development of methods and means for the determination of cAMP concentrations both in vitro and in vivo.
Latest Patents
Moritz Bunemann holds a patent titled "Means And Methods For The Determination Of Camp In Vitro And In Vivo." This invention relates to a chimeric peptide that includes a cAMP binding moiety with a single binding site and two detectable labels. The first label is positioned at the carboxy terminus, while the second is located at the amino terminus of the cAMP binding moiety. This chimeric peptide is particularly useful for the direct determination of cAMP concentrations in various biological samples. The patent also describes nucleic acid molecules encoding the chimeric proteins, as well as methods for producing these proteins and screening compounds that can modify cAMP binding.
Career Highlights
Moritz Bunemann is affiliated with the Bayerische Julius-Maximilians-Universität Würzburg, where he conducts research and contributes to advancements in his field. His work has significant implications for understanding cellular signaling and the pharmacological functions of adenylyl cyclases and phosphodiesterases.
Collaborations
Throughout his career, Moritz Bunemann has collaborated with esteemed colleagues, including Viacheslav Nikolaev and Martin J. Lohse. These collaborations have further enriched his research and contributed to the scientific community's understanding of cAMP dynamics.
Conclusion
Moritz Bunemann's innovative work in the field of cAMP research exemplifies the importance of scientific inquiry in understanding complex biological processes. His contributions continue to influence the development of new methods for studying cellular signaling.